March 21, 2019
Imago BioSciences Announces $40 Million Series B Financing Led by Omega Funds
SAN FRANCISCO–(BUSINESS WIRE)–Imago BioSciences, Inc., a clinical-stage biotechnology company developing innovative treatments for myeloid diseases, today announced a $40 million…